[Duration of the therapeutic effect of a beta 2 stimulant (procaterol hydrochloride) in patients with asthmatiform bronchopathies].
Cammarata
A
A
Mazzarella
G
G
Grella
E
E
Liccardo
G
G
D000293:Adolescent; D000318:Adrenergic beta-Agonists / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D001249:Asthma / Q000188:drug therapy* / Q000503:physiopathology; D001985:Bronchial Provocation Tests; D001993:Bronchodilator Agents / Q000627:therapeutic use*; D004983:Ethanolamines / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D017265:Procaterol; D013997:Time Factors; D014797:Vital Capacity
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D004983:Ethanolamines; D017265:Procaterol
Durata dell'effetto terapeutico di un preparato beta 2 stimolante (procaterolo cloridrato) in pazienti broncopatici ad impronta asmatiforme.